News

Medidata announces a collaboration with New York’s Memorial Sloan Kettering Cancer Center on a pilot study to expand the use of mHealth technology in oncology treatment.

The European Medicines Agency (EMA) is proposing changes to the current guidelines on first-in-human clinical trials to improve risk-based strategies. This proposal was made with cooperation from the European Commission and the Member States of the European Union (EU).

Continuous Glucose Monitoring (CGM) devices have the ability to replace the traditional finger-prick to measure glucose levels in a patient’s blood. Quintiles’ device expert, Sam Osman, explains CGM and how the FDA decision could affect clinical trials.

khowells_headshot.jpeg

OmniComm’s Keith Howells speaks to ACT about whether electronic data capture (EDC) can be considered innovative in today's pharma.

With North America and Europe accounting for the majority of active clinical trial sites in 2016, the need for globalization is increasing. Brazil, Russia, India and China are emerging markets with potential, but not without challenges.